• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Lacosamide for refractory generalized tonic-clonic seizures of non-focal origin in clinical practice: A clinical and VEEG study.拉科酰胺用于临床实践中起源于非局灶性的难治性全面强直阵挛发作:一项临床及视频脑电图研究。
Epilepsy Behav Case Rep. 2017 Aug 24;8:63-65. doi: 10.1016/j.ebcr.2017.08.001. eCollection 2017.
2
Two-year efficacy of lacosamide as adjunctive therapy for generalized tonic-clonic seizures in patients with juvenile myoclonic epilepsy.左乙拉西坦添加治疗青少年肌阵挛癫痫患者全面强直-阵挛发作的两年疗效。
Brain Dev. 2023 Sep;45(8):451-455. doi: 10.1016/j.braindev.2023.05.007. Epub 2023 Jun 10.
3
Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.拉莫三嗪辅助治疗儿童和青少年原发性全面性强直阵挛发作。
Pediatrics. 2006 Aug;118(2):e371-8. doi: 10.1542/peds.2006-0148. Epub 2006 Jul 17.
4
Efficacy of Lacosamide in a Patient with Refractory Generalized Epilepsy Based on Video Electroencephalography.基于视频脑电图的拉考沙胺治疗耐药性全面性癫痫的疗效。
Intern Med. 2021 Nov 15;60(22):3621-3624. doi: 10.2169/internalmedicine.7295-21. Epub 2021 May 29.
5
Overlap cases of eyelid myoclonia with absences and juvenile myoclonic epilepsy.眼睑肌阵挛伴失神发作与青少年肌阵挛癫痫的重叠病例。
Seizure. 2006 Sep;15(6):359-65. doi: 10.1016/j.seizure.2006.02.006. Epub 2006 Jun 21.
6
Lacosamide for uncontrolled primary generalized tonic-clonic seizures: An open-label pilot study with 59-week extension.拉科酰胺用于治疗无法控制的原发性全面强直阵挛发作:一项为期59周扩展期的开放标签试点研究。
Epilepsy Res. 2017 Feb;130:13-20. doi: 10.1016/j.eplepsyres.2016.12.015. Epub 2016 Dec 29.
7
Epilepsy with myoclonic absences: Electroclinical characteristics in a distinctive pediatric epilepsy phenotype.伴有肌阵挛失神发作的癫痫:一种独特的小儿癫痫表型的电临床特征
Epilepsy Behav. 2016 Nov;64(Pt A):242-247. doi: 10.1016/j.yebeh.2016.08.023. Epub 2016 Oct 19.
8
Accidental injuries in patients with generalized tonic-clonic seizures. A multicenter, observational, cross-sectional study (QUIN-GTC study).全面性强直-阵挛发作患者的意外伤害。一项多中心、观察性、横断面研究(QUIN-GTC 研究)。
Epilepsy Behav. 2019 Mar;92:135-139. doi: 10.1016/j.yebeh.2018.10.043. Epub 2019 Jan 15.
9
Epileptology of the first tonic-clonic seizure in adults and prediction of seizure recurrence.成人首次强直-阵挛性发作的癫痫学及发作复发预测
Epileptic Disord. 2018 Dec 1;20(6):490-501. doi: 10.1684/epd.2018.1014.
10
Use of topiramate in childhood generalized seizure disorders.托吡酯在儿童全身性癫痫疾病中的应用。
J Child Neurol. 2000;15 Suppl 1:S7-13. doi: 10.1177/0883073800015001S03.

引用本文的文献

1
Response of focal refractory status epilepticus to lacosamide in an infant.婴儿局灶性耐药性癫痫持续状态对拉科酰胺的反应。
BMJ Case Rep. 2022 Apr 29;15(4):e249948. doi: 10.1136/bcr-2022-249948.
2
Efficacy of Lacosamide in a Patient with Refractory Generalized Epilepsy Based on Video Electroencephalography.基于视频脑电图的拉考沙胺治疗耐药性全面性癫痫的疗效。
Intern Med. 2021 Nov 15;60(22):3621-3624. doi: 10.2169/internalmedicine.7295-21. Epub 2021 May 29.
3
Experimental Therapeutic Strategies in Epilepsies Using Anti-Seizure Medications.使用抗癫痫药物治疗癫痫的实验性治疗策略
J Exp Pharmacol. 2021 Mar 11;13:265-290. doi: 10.2147/JEP.S267029. eCollection 2021.
4
Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial.左乙拉西坦辅助治疗原发性全面强直-阵挛发作的疗效和安全性:一项双盲、随机、安慰剂对照试验。
J Neurol Neurosurg Psychiatry. 2020 Oct;91(10):1067-1075. doi: 10.1136/jnnp-2020-323524. Epub 2020 Aug 18.
5
Genetic generalized and focal epilepsy prevalence in the North American SUDEP Registry.北美 SUDEP 注册中心的遗传性全面性和局灶性癫痫患病率。
Neurology. 2020 Apr 21;94(16):e1757-e1763. doi: 10.1212/WNL.0000000000009295. Epub 2020 Mar 26.
6
Genomic and clinical predictors of lacosamide response in refractory epilepsies.难治性癫痫中拉科酰胺反应的基因组和临床预测指标
Epilepsia Open. 2019 Sep 25;4(4):563-571. doi: 10.1002/epi4.12360. eCollection 2019 Dec.

本文引用的文献

1
Unmasking of myoclonus by lacosamide in generalized epilepsy.拉科酰胺在全身性癫痫中对肌阵挛的揭示作用
Epilepsy Behav Case Rep. 2016 Nov 16;7:28-30. doi: 10.1016/j.ebcr.2016.09.006. eCollection 2017.
2
Lacosamide for uncontrolled primary generalized tonic-clonic seizures: An open-label pilot study with 59-week extension.拉科酰胺用于治疗无法控制的原发性全面强直阵挛发作:一项为期59周扩展期的开放标签试点研究。
Epilepsy Res. 2017 Feb;130:13-20. doi: 10.1016/j.eplepsyres.2016.12.015. Epub 2016 Dec 29.
3
Current understanding of the mechanism of action of the antiepileptic drug lacosamide.抗癫痫药物拉科酰胺作用机制的当前认识。
Epilepsy Res. 2015 Feb;110:189-205. doi: 10.1016/j.eplepsyres.2014.11.021. Epub 2014 Dec 3.
4
Efficacy and tolerability of lamotrigine in juvenile myoclonic epilepsy in adults: a prospective, unblinded randomized controlled trial.拉莫三嗪治疗成人青少年肌阵挛癫痫的疗效和耐受性:一项前瞻性、非盲、随机对照试验。
Seizure. 2013 Dec;22(10):846-55. doi: 10.1016/j.seizure.2013.07.006. Epub 2013 Aug 1.
5
Lacosamide treatment of juvenile myoclonic epilepsy.拉考酰胺治疗青少年肌阵挛癫痫。
Seizure. 2012 Apr;21(3):202-4. doi: 10.1016/j.seizure.2011.12.010. Epub 2012 Jan 26.
6
Lacosamide use in refractory idiopathic primary generalized epilepsy.拉考沙胺治疗难治性特发性全面性癫痫。
Epilepsy Behav. 2012 Jan;23(1):79-80. doi: 10.1016/j.yebeh.2011.10.023. Epub 2011 Dec 23.
7
Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009.修订的癫痫发作和癫痫分类术语和概念:国际抗癫痫联盟分类和术语委员会 2005-2009 年报告。
Epilepsia. 2010 Apr;51(4):676-85. doi: 10.1111/j.1528-1167.2010.02522.x. Epub 2010 Feb 26.
8
Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy.特发性全身性癫痫中抗癫痫药物诱发的失神和肌阵挛癫痫持续状态。
Brain. 2006 May;129(Pt 5):1281-92. doi: 10.1093/brain/awl047. Epub 2006 Mar 2.
9
Treatment of refractory primary generalized epilepsy.难治性原发性全身性癫痫的治疗。
Rev Neurol Dis. 2004;1 Suppl 1:S34-43.
10
Seizure aggravation in idiopathic generalized epilepsies.特发性全身性癫痫中的癫痫发作加重
Epilepsia. 2005;46 Suppl 9:133-9. doi: 10.1111/j.1528-1167.2005.00325.x.

拉科酰胺用于临床实践中起源于非局灶性的难治性全面强直阵挛发作:一项临床及视频脑电图研究。

Lacosamide for refractory generalized tonic-clonic seizures of non-focal origin in clinical practice: A clinical and VEEG study.

作者信息

Abarrategui Belén, García-García María Eugenia, Toledano Rafael, Parejo-Carbonell Beatriz, Gil-Nagel Antonio, García-Morales Irene

机构信息

Epilepsy Unit, Department of Neurology, Hospital Clínico San Carlos, Profesor Martín Lagos s/n, 28040 Madrid, Spain.

Epilepsy Unit, Department of Neurology, Hospital Ruber Internacional, La Masó 38, Mirasierra, 28034 Madrid, Spain.

出版信息

Epilepsy Behav Case Rep. 2017 Aug 24;8:63-65. doi: 10.1016/j.ebcr.2017.08.001. eCollection 2017.

DOI:10.1016/j.ebcr.2017.08.001
PMID:28948142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5602820/
Abstract

•7 of 9 patients with GGE reduced ≥ 50% their tonic-clonic seizure frequency on LCM.•All 7 patients remained seizure free for > 1 year, and 2 of them for > 5 years.•In 2 of the 9 patients, both with Juvenile Absence Epilepsy, absences aggravated.•One aggravation consisted on a myoclonia and absence status, in a patient with no history of myoclonia.•VEEG paralleled clinical improvement but didn't change in a case of absence worsening.

摘要

•9例全面性癫痫伴中央颞区棘波(GGE)患者中有7例在服用拉考沙胺(LCM)后强直阵挛发作频率降低≥50%。

•所有7例患者均有>1年无癫痫发作,其中2例>5年无癫痫发作。

•9例患者中有2例均为青少年失神癫痫,失神发作加重。

•1例加重表现为肌阵挛和失神持续状态,该患者既往无肌阵挛病史。

•视频脑电图(VEEG)与临床改善情况平行,但在1例失神发作恶化的病例中无变化。